Polygenic risk for Alzheimer's disease is associated with neuroaxonal damage before onset of clinical symptoms

Sonja M. Kagerer*, Swapnil Awasthi, Stephan Ripke, Aleksandra Maceski, Pascal Benkert, Aïda B. Fall, Peter Riederer, Peter Fischer, Susanne Walitza, Edna Grünblatt, Jens Kuhle, Paul G. Unschuld

*Corresponding author for this work

Research output: Contribution to journalJournal articleResearchpeer-review

25 Downloads (Pure)

Abstract

INTRODUCTION: Establishing valid diagnostic strategies is a precondition for successful therapeutic intervention in Alzheimer's disease (AD). METHODS: One hundred forty-four healthy 75-year-old participants from the Vienna-Transdanube-Aging longitudinal cohort study were tested for neuroaxonal damage by single molecular array (Simoa) plasma neurofilament light chain (NfL) levels at baseline, 30, 60, and 90 months, and onset of AD dementia. Individual risk for sporadic AD was estimated by continuous shrinkage polygenic risk score (PRS-CS, genome-wide association study). RESULTS: Nineteen participants developed AD after a median of 60 months (interquartile range 30). In participants with AD, baseline NfL plasma levels correlated with PRS-CS (r = 0.75, p < 0.001; difference to controls: Fisher's r-to-z: z = 3.89, p < 0.001). PRS-CS combined with baseline plasma NfL predicted onset of AD (p < 0.01). DISCUSSION: Our data suggest that polygenic risk for AD and plasma NfL closely interact years before onset of clinical symptoms. Peripheral NfL may serve as a diagnostic measure supporting early therapeutic intervention and secondary prevention in AD.

Original languageEnglish
Article numbere12504
JournalAlzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring
Volume16
Issue number1
Number of pages9
ISSN2352-8729
DOIs
Publication statusPublished - 1. Jan 2024

Keywords

  • Alzheimer's disease
  • genome-wide association studies
  • neurofilament light chain
  • plasma biomarker
  • polygenic risk score
  • single molecular array

Fingerprint

Dive into the research topics of 'Polygenic risk for Alzheimer's disease is associated with neuroaxonal damage before onset of clinical symptoms'. Together they form a unique fingerprint.

Cite this